|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.870 USD | -0.84% |
|
+1.73% | -45.15% |
| 06-06 | Bolt Biotherapeutics Announces 120 Reverse Stock Split Effective June 6, 2025 | RE |
| 05-12 | Bolt Biotherapeutics, Inc. - Special Call |
EPS & Dividend: Bolt Biotherapeutics, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -59.4 | -47.2 | -36.6 | -33 | -24.75 | -22.35 | -17.6 |
| Distribution rate | - | - | - | - | - | - | - |
| Reference price 2 | 98.000 | 26.000 | 22.400 | 10.702 | 5.870 | 5.870 | 5.870 |
| Nbr of stocks (in thousands) | 1,864 | 1,883 | 1,898 | 1,914 | 1,917 | - | - |
| Announcement Date | 30/03/22 | 29/03/23 | 21/03/24 | 24/03/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Bolt Biotherapeutics, Inc.
| 05/08/2025 | Q2 2025 Earnings Release (Projected) |
| 05/11/2025 | Q3 2025 Earnings Release (Projected) |
| 31/03/2026 | Q4 2025 Earnings Release (Projected) |
| 06/05/2026 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| - | - | -0.24x | - | - | ||
| -.--% | -.--% | 47.53x | 5.13x | 8.06x | ||
| 1.69% | 1.94% | 17.11x | 3x | 4.21x | ||
| -.--% | -.--% | -23.26x | 1.25x | 5.74x | ||
| -.--% | -.--% | -18.2x | 89.81x | 40.62x | ||
| -.--% | -.--% | -52.36x | - | - | ||
| -.--% | -.--% | 23.73x | 1.97x | 4.15x | ||
| -.--% | -.--% | 2026.06x | 13.42x | 26.15x | ||
| -.--% | -.--% | 12.7x | 1.96x | 2.42x | ||
| -.--% | -.--% | 19.23x | 4.32x | 4.61x | ||
| Average | 0.19% | 0.22% | 205.23x | 15.11x | 11.99x | |
| Weighted average by Cap. | 0.27% | 0.31% | 155.53x | 14.09x | 11.23x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition